Associate Director, Medical & Professional Relations MannKind Corporation
Join us to hear from Dr. Jennifer Rittenberry as she provides a clinical overview of ultra rapid-acting inhaled insulin, including clinical data as well as insights on dosing and safety.
.jpg)
